Leveraging Engineered Bacteriophages to Target Cancer Cells & Induce an Immune Response Against Tumors
Time: 2:30 pm
day: Conference Day One
Details:
- Utilizing non-lytic filamentous bacteriophages for their shape and ease of purification as the basis for immunotherapy
- Developing the nanofilament TAT003 as an immunotherapy injected directly to the tumor and stick to cancer cells, reshape the surface and activate the immune system
- Fusing cancer protein genes and therapeutic genes to the bacteriophage to achieve antitumor response
New Company!
New Data!
